Trials / Unknown
UnknownNCT03144622
18F-FSPG PET/CT Imaging in Patients With Cancers
(4S)-4-(3-[18F]Fluoropropyl)-L-glutamate Radiotracer (FSPG) PET/CT for Imaging xC- Transporter Activity in Cancers
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- National Taiwan University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to compare the diagnostic performance of 18F-FDG and 18F-FSPG PET/CT in lung, breast, and abdominal cancers before undergoing therapy. In addition, the role of 18F-FSPG PET/CT in evaluating therapy response and prognosis will also be evaluated.
Conditions
Timeline
- Start date
- 2016-09-06
- Primary completion
- 2019-12-31
- Completion
- 2022-12-31
- First posted
- 2017-05-09
- Last updated
- 2019-10-30
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT03144622. Inclusion in this directory is not an endorsement.